Published in Indian J Nephrol on October 01, 2011
Phosphate control in dialysis. Int J Nephrol Renovasc Dis (2013) 0.91
Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis. Pediatr Nephrol (2015) 0.78
Use of nicotinamide to treat hyperphosphatemia in dialysis patients. Drugs R D (2013) 0.78
Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease. Indian J Nephrol (2016) 0.75
Niacin for phosphate control: A case of David versus Goliath. Indian J Nephrol (2016) 0.75
Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer. Breast Cancer (Dove Med Press) (2014) 0.75
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis (2003) 16.18
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int (2006) 6.61
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int (2005) 3.71
Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int (2006) 3.36
Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int (2004) 3.12
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis (2000) 2.65
Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem (2003) 2.52
Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr (2008) 2.48
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29
Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care (2007) 1.92
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia. Lancet (1983) 1.73
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins (1989) 1.49
A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation (2000) 1.40
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant (2005) 1.29
Characterization of a G protein-coupled receptor for nicotinic acid. Mol Pharmacol (2001) 1.28
Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure. Nephrol Dial Transplant (2005) 1.24
Safety of high-dose nicotinamide: a review. Diabetologia (2000) 1.22
Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine. Nephrol Dial Transplant (1999) 1.22
Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol (2003) 1.16
A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.10
Mild hyperphosphatemia and mortality in hemodialysis patients. Am J Kidney Dis (2005) 1.09
Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study. Nephrol Dial Transplant (2005) 1.08
Extended release nicotinic acid - a novel oral agent for phosphate control. Int Urol Nephrol (2006) 1.07
Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat. J Clin Invest (1981) 1.06
Nicotinamide is a brain constituent with benzodiazepine-like actions. Nature (1979) 1.00
Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients. Clin J Am Soc Nephrol (2007) 1.00
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush. Atherosclerosis (2006) 0.97
Newly discovered anti-inflammatory properties of the benzamides and nicotinamides. Mol Cell Biochem (1999) 0.95
Nicotinamide restores phosphaturic effect of PTH and calcitonin in phosphate deprivation. Am J Physiol (1982) 0.89
Management of hyperphosphatemia. Hemodial Int (2006) 0.89
Modulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase. Inflammation (1995) 0.82
Phosphate transport adaptation in rat jejunum and plasma level of 1,25-dihydroxyvitamin D3. Scand J Gastroenterol (1990) 0.81
Central effects of nicotinamide and inosine which are not mediated through benzodiazepine receptors. Br J Pharmacol (1985) 0.79
A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients. Nephrol Dial Transplant (2002) 0.78
Treatment with sevelamer decreases bicarbonate levels in peritoneal dialysis patients. Perit Dial Int (2003) 0.77
Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog. Neuroscience (2005) 1.08
Sex-specific changes in gene expression and behavior induced by chronic Toxoplasma infection in mice. Neuroscience (2012) 1.04
The risk factors and outcome of fungal peritonitis in continuous ambulatory peritoneal dialysis patients. Indian J Med Microbiol (2009) 1.01
Sericea lespedeza hay as a natural deworming agent against gastrointestinal nematode infection in goats. Vet Parasitol (2006) 0.95
The effects of feeding sericea lespedeza hay on growth rate of goats naturally infected with gastrointestinal nematodes. J Anim Sci (2008) 0.95
Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India. Hemodial Int (2005) 0.94
Evaluation of the immunomodulatory and DNA protective activities of the shoots of Cynodon dactylon. J Ethnopharmacol (2009) 0.91
Efficacy of sericea lespedeza hay as a natural dewormer in goats: dose titration study. Vet Parasitol (2009) 0.87
Cadaveric renal transplantation: the Chennai experience. Transplant Proc (2008) 0.85
Blastocystis hominis--an emerging cause of diarrhoea in renal transplant recipients. J Assoc Physicians India (2003) 0.83
A study of drug-drug interactions in cancer patients of a south Indian tertiary care teaching hospital. J Postgrad Med (2011) 0.83
Peritoneal dialysis in a patient with neurogenic bladder and chronic kidney disease with ventriculoperitoneal shunt. Blood Purif (2008) 0.82
Pharmacokinetic evaluation of Paclitaxel in South Indian cancer patients: a prospective study. J Young Pharm (2011) 0.81
Prediction of Malnutrition Using Modified Subjective Global Assessment-dialysis Malnutrition Score in Patients on Hemodialysis. Indian J Pharm Sci (2011) 0.81
Renal transplantation in a HIV positive patient. Indian J Nephrol (2009) 0.81
Effectiveness of physical activity promotion in blood pressure and blood sugar reduction: a community-based intervention study in rural south India. J Family Community Med (2012) 0.78
Drug usage evaluation of dapsone. Indian J Pharm Sci (2009) 0.78
Improvement of banana cv. Rasthali (Silk, AAB) against Fusarium oxysporum f.sp. cubense (VCG 0124/5) through induced mutagenesis: Determination of LD50 specific to mutagen, explants, toxins and in vitro and in vivo screening for Fusarium wilt resistance. Indian J Exp Biol (2016) 0.76
Acute stridor and wheeze as an initial manifestation of hypocalcemia in an infant. Indian J Endocrinol Metab (2012) 0.75
A simple and practical method for assessing the adequacy of hemodialysis. ASAIO Trans (1992) 0.75
Klebsiella endocarditis in the early post-operative period after renal transplantation. Nephrol Dial Transplant (1998) 0.75
Nocardial endophthalmitis leading to blindness in a renal transplant recipient. Nephrol Dial Transplant (1999) 0.75
Osteosarcoma in an infant. Indian Pediatr (1986) 0.75